CSF neurofilament levels: A potential prognostic marker in Guillain–Barré syndrome

Authors:
  • NHN. Hinds
    N. Hinds
  • NMNm F. Murray
    Nm F. Murray
  • NHN. P. Hirsch
    N. P. Hirsch
  • DGD. Grant
    D. Grant
  • GKG. Keir
    G. Keir
  • ETE. J. Thompson
    E. J. Thompson
  • MRM. M. Reilly
    M. M. Reilly

Abstract
Long-term morbidity from Guillain–Barré syndrome (GBS) is caused by axonal damage. This prospective study demonstrated that neurofilaments (NfHs), a biomarker for axonal damage, were of prognostic value in GBS. CSF NfH levels correlated with the F score and Medical Research Council summed score and were higher in patients with neurophysiologic evidence of axonal degeneration compared to those without. Pathologically high CSF NfH levels (>0.73 ng/mL) predicted worse motor and functional outcome.